Boston Scientific Corp.
Market cap $63.6B
$43.45
BSX
$43.45
-1.05% today
Buy with €1M virtual cash · No real money
Boston Scientific Corp. (BSX) is a publicly traded company listed on the XNYS. As of September 17, 2026, Invest's signal rates BSX a Sell, with the stock down 56% over the past year. You can practice trading BSX risk-free with €1,000,000 in virtual cash.
Key stats
As of September 17, 2026
Market Cap
$63.6B
Volume
15.9M
52-wk High
$105.65
52-wk Low
$42.20
Day High
$43.66
Day Low
$42.95
P/E (TTM)
17.59
Revenue (TTM)
$21.0B
EPS (TTM)
$2.47
Performance
1M
-13.9%
6M
-39.0%
1Y
-56.1%
Invest signal · BSX
SellAlgorithmic signal from price trend, valuation, and fundamentals — educational only, not financial advice.
BSX overview
AI overviewRevenue & EPS — last 8 quarters
QoQ rev +4.6%Revenue
$5BEPS (diluted)
$0.61 per shareLatest BSX news
Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic?
Zacks Investment Research · 6d ago
Medtronic Is on the Cusp of Becoming a Dividend King. Is the Stock a Buy for Income Investors?
The Motley Fool · Sep 9
Medtronic Raises 2027 Outlook as Broad-Based Growth Gains Momentum
Zacks Investment Research · Sep 9
Novocure Reports Patient Data Exposure in Cybersecurity Incident
Zacks Investment Research · Sep 7
Renal Denervation Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)
GlobeNewswire Inc. · Sep 4
About Boston Scientific Corp.
Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally.
Foreign sales account for roughly 36% of the firm's total sales.
Employees
59,000
30-Day Win Rate · BSX
10 days
14 days
Last 24 sessions
How to practice trading BSX
- 1
Use the BSX buy panel above
Set a quantity and hit Buy at the real market price — right here, nothing to download.
- 2
Trade with €1,000,000 virtual cash
You get a million in virtual money instantly to invest, risk-free.
- 3
Create a free account to save it
Sign up in seconds to keep your portfolio and track its performance.
- 4
Track and compete
Watch your portfolio grow and climb the global leaderboard — or start a private league.
- 5
Prefer mobile? Get the iOS app
Invest is also free on the App Store, synced with your web account.
Top BSX traders on Invest
Full leaderboardFrequently asked questions
Is BSX a good stock to buy right now?
As of September 17, 2026, Invest's signal rates BSX a Sell, based on its price trend, valuation, and fundamentals (P/E around 17.6), with the stock down 56% over the past year. This is an educational signal, not financial advice — the best way to test the thesis is to practice trading BSX risk-free first.
What is Boston Scientific Corp.'s (BSX) market cap?
Boston Scientific Corp. has a market capitalization of approximately $63.6B, on trailing-twelve-month revenue of about $21.0B.
How has BSX stock performed?
BSX is down 56% over the past year and down 39% over six months. Its 52-week range runs roughly from $42.20 to $105.65. Past performance doesn't predict future results.
How can I practice trading BSX for free?
On Invest you get €1,000,000 in virtual cash and can buy BSX at real market prices right in your browser — no download and no real money at risk. Create a free account to save your portfolio and track its performance over time.
More stocks to practice
Designs the iPhone, Mac, and a huge services ecosystem.
Windows, Office, Azure cloud, and enterprise software.
The leading designer of AI and gaming GPUs.
E-commerce giant and the largest cloud provider (AWS).
Google Search, YouTube, Android, and cloud.
Facebook, Instagram, WhatsApp, and the metaverse.
Compare BSX with peers